Editor's Choice

Stay up to date with the latest industry updates from the global practical patient care industry.

Latest Update

InfectoGnostics study: Benefits of on-site tests in general practices
29 September, 2023
Interview with Anni Matthes and Dr. Robby Markwart, Research...
> read more

Editor's Choice

Sun Nuclear SunSCAN™ 3D Water Scanning System Receives CE Marking
Friday, September 29, 2023 by Faster, Hyper-Accurate Commissioning and Beam Scanning Solution Now Available in Countries Requiring CE Marking

Diana Bracco: "Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses"
Friday, September 29, 2023 by Unlocking the AI Revolution - A Symposium on the future of the Healthcare Industry and Diagnostic Imaging in the era of Artificial Intelligence is the title describing the theme of...

Huawei Accelerates Intelligent Healthcare with the Innovative Digital Medical Technology Solution
Friday, September 29, 2023 by During HUAWEI CONNECT 2023, Huawei held the first intelligent healthcare summit themed "Build a Digital Health Community to Accelerate Intelligent Healthcare". Huawei released the...

Clario teams up with CellCarta to transform clinical trial sample management for histopathology studies
Friday, September 29, 2023 by Clario, a healthcare research technology company that delivers the leading endpoint technology solutions for clinical trials, proudly announces a strategic partnership with...

British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day
Friday, September 29, 2023 by CaRi-Heart® Users share Excitement on Potential for Heart Attack Prediction and Prevention

QIAGEN extends AI capabilities of its NGS interpretation software QCI Interpret to enable clinical exome completeness
Friday, September 29, 2023 by QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the expansion of its clinical decision support software, QIAGEN Clinical Insight Interpret (QCI Interpret), to...

Jonas Jarvius to step down as CEO of Q-linea during 2024
Friday, September 29, 2023 by Jonas Jarvius has informed Q-linea AB:s (publ) (OMX: QLINEA) board of directors that he plans to step down as CEO before summer 2024 to take over as CEO of a US based life...

Revvity Expands Access to Base Editing Technology With Aim to Accelerate Discovery to Cure
Friday, September 29, 2023 by Revvity, Inc., (NYSE: RVTY) today unveils its groundbreaking Pin-point™ base editing platform reagents, providing researchers with unparalleled access to implement the advanced...

Hologic and Bayer Announce International Partnership to Deliver Comprehensive Contrast-Enhanced Mammography Package to Breast Imaging Facilities
Friday, September 29, 2023 by Partnership Includes Education and Training to Increase Clinician Confidence in the Use of CEM, an Emerging Breast Imaging Modality

QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
Friday, September 22, 2023 by QuidelOrtho Corporation (Nasdaq: QDEL)(“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and...

Deep Bio Announces Market Authorization from Swissmedic for DeepDx Prostate, Paving the Way for European Expansion
Wednesday, September 20, 2023 by Deep Bio, a leader in artificial intelligence (AI)-powered cancer diagnostics, announced today that it has obtained marketing authorization from Swissmedic for DeepDx Prostate,...

Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost
Wednesday, September 20, 2023 by Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, today announced it will provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges...

GT Molecular Launches Multiplexed Assay Kit for Respiratory Pathogen Detection on the Roche Digital LightCycler® System
Wednesday, September 20, 2023 by GT Molecular, Inc., a company providing ultrasensitive PCR assays for wastewater-based epidemiology testing, pathogen detection, and cancer research is pleased to announce an...

Innovative diagnostics and the use of AI allow individualised approaches in performance medicine, prevention of injuries and therapy
Tuesday, September 19, 2023 by High calibre speakers at the MEDICA MEDICINE + SPORTS CONFERENCE illuminate new methods and their practical uses

QIAGEN launches API to streamline access to world-leading biomedical data for AI integration
Monday, September 11, 2023 by Venlo, the Netherlands, and Redwood City, California, September 11, 2023 – QIAGEN Digital Insights, the bioinformatics business of QIAGEN, today announced the launch of an...

BioGX Expands Xfree Respiratory PCR With COVID-19/Flu A/Flu B Multiplex, Group A Streptococcus, Mycoplasma Pneumoniae
Monday, September 11, 2023 by BioGX, a global provider of molecular diagnostic solutions, announces the availability of three new Xfree™ Direct-Sample-to-Answer PCR multiplexes for the detection of Group...

US FDA Grants Emergency Use Authorisation For ViraDx™
Monday, September 11, 2023 by Lumos Diagnostics (ASX: LDX), (“Lumos” or the “Company”) a leader in rapid, point-of-care (POC) diagnostic technologies, is pleased to announce that the US Food and Drug...

Bruker’s New NeuraLeap Delivers Unprecedented Imaging Speed Across Optical Planes
Thursday, September 07, 2023 by Novel Use of Digital Micromirror Device Enables Variable Depth-of-Field Collection for Advanced Neuroscience Research

MEDICA LABMED FORUM: four exciting topic days around hot issues, current trends and innovations in laboratory medicine
Tuesday, September 05, 2023 by Important ideas for the entire health market

Editor's Choice Archive

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.